An interventional study of AI program for colonoscopy in Colorectal Cancer, sponsored by University of Minnesota. Suspended at 3 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-09.
Sponsored by University of Minnesota · Not applicable, Interventional, and Treatment
To test whether real-time feedback will improve quality of endoscopic examination.
5,599 studies on the registry are indexed under Colorectal Neoplasms; 1,459 are open to participants now.
This study's planned enrollment of 4,150 is above the median of 77 across 4,123 interventional studies indexed under Colorectal Neoplasms.
Browse Colorectal Neoplasms studies →University of Minnesota is the lead sponsor of 1,184 studies on the registry; 195 are open to participants now.
Of its 132 completed or terminated interventional studies of FDA-regulated products, 91 (69%) have results posted.
Counted across the registry records on this site, refreshed daily.
- Any endoscopist willing to parcipate and performing routine colonscopy
Exclusion Criteria:
- No exclusion criteria
AI provides real-time feedback related to circumferential views during endoscope removal
Device: AI program for colonoscopy
AI provides real-time feedback related to removal of remaining fecal debris
Device: AI program for colonoscopy
Provides real-time feedback on the endoscopist moniter during colonoscopy.
Adenoma Detection Rate
Percent change in ADR
Time frame: 5 months post procedure
Plan to share: No
No publications or documents are linked to this record.
This study is suspended, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Minnesota